Buscar

Medicamentos na Prática Clinica - Barros - 1ed_Parte32

Prévia do material em texto

32 Elvino Barros, Helena M. T. Barros & Cols. 
deve-se fazer o relato por meio de ficha de far1nacovigilância específica, que 
pode ser encontrada no site da Anvisa. 
REFERÊNCIAS 
Arrnstrong D, Reyburn H, Jones R. A study of general practitioners' reasons for changing their 
prescribing behaviour. Br Med J. 1996;312(7036) :949-52. 
Barber N. What constitutes good prescribing? Br Med J. 1995;310(6984):923-5. 
Bradley CP. Decision making and prescribing pattems: a literature review. Fam Pract. 
1991;8(3) :276-87. 
Brasil. Portaria 344, de 12 de maio de 1998. Aprova o regulamento sobre substâncias e medica-
mentos sujeitos a controle especial. DOU. 1999(21):29-53. Seção 1. 
Freemantle N, Henry D, Maynard A, Torrance G. Promoting cost effective prescribing. Br Med J. 
1995;310(6985):955-6. 
lnman W, Pearce G. Prescriberprofile and post-marketing surveillance. Lancet. 1993 ;342 (88 72) :658-
61. 
Marley J, Mant A. Post marketing surveillance: traps for the unwary. Aust Fam Physician. 
1993;22(6):1009-11, 1013. 
Marley J. Cost-effectiveness: the need to know [editorial]. Aust Prescr. 1996;19:58-9 
Marley J. Efficacy, effectiveness, efficiency. Aust Prescr. 2000;23(6):114-5 
Martim RM. When to use a new drug. Aust Prescr. 1998;21:67-9. 
Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP. Barriers and facilitators of medi-
cation adherence in hypertensive African Americans: a qualitative study. Ethn Dis. 2004;14(1):3-
12. 
Taylor RJ, Bond CM. Change in the established prescribing habits of general practitioners: an 
analysis of initial prescriptions in general practice. Br J Gen Pract. 1991;41(347):244-8. 
Waller PC, Wood SM, Langman MJ, Breckenridge AM, Rawlins MD. Review of company postma-
rketing surveillance studies. Br Med J. 1992;304(6840):1470-2. 
World Health Organization. WHO model listo f essential medicines [homepage in the Internet]. 
Geneva: Author; 2007 [acesso 2009 Oct 16]. Disponível em: http://www.who.int/medicines/pu-
blications/EML15. pdf 
	Medicamentos na Prática Clinica - Barros - 1ed

Continue navegando